Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

NCT05040971 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Semaglutide 2.4 mg
DRUG: Placebo

Sponsor

Novo Nordisk A/S